140 related articles for article (PubMed ID: 3088397)
21. Protection of mice against herpes simplex virus infection by a Lactobacillus casei preparation (LC 9018) in combination with inactivated viral antigen.
Watanabe T; Saito H
Microbiol Immunol; 1986; 30(2):111-22. PubMed ID: 3012292
[TBL] [Abstract][Full Text] [Related]
22. Lactobacillus casei and Lactobacillus acidophilus regulate inflammatory pathway and improve antioxidant status in collagen-induced arthritic rats.
Amdekar S; Singh V; Kumar A; Sharma P; Singh R
J Interferon Cytokine Res; 2013 Jan; 33(1):1-8. PubMed ID: 23030670
[TBL] [Abstract][Full Text] [Related]
23. Oral immunization with recombinant Lactobacillus casei expressing OmpAI confers protection against Aeromonas veronii challenge in common carp, Cyprinus carpio.
Zhang DX; Kang YH; Chen L; Siddiqui SA; Wang CF; Qian AD; Shan XF
Fish Shellfish Immunol; 2018 Jan; 72():552-563. PubMed ID: 29155272
[TBL] [Abstract][Full Text] [Related]
24. Enhanced immune response to pneumococcal infection in malnourished mice nasally treated with heat-killed Lactobacillus casei.
Villena J; Barbieri N; Salva S; Herrera M; Alvarez S
Microbiol Immunol; 2009 Nov; 53(11):636-46. PubMed ID: 19903264
[TBL] [Abstract][Full Text] [Related]
25. Role of colony-stimulating activity in antitumor activity of Lactobacillus casei in mice.
Shimizu T; Nomoto K; Yokokura T; Mutai M
J Leukoc Biol; 1987 Sep; 42(3):204-12. PubMed ID: 3114399
[TBL] [Abstract][Full Text] [Related]
26. The intraperitoneal inoculation of Lactobacillus casei in mice induces total protection against Trichinella spiralis infection at low challenge doses.
Martínez-Gómez F; Fuentes-Castro BE; Bautista-Garfias CR
Parasitol Res; 2011 Dec; 109(6):1609-17. PubMed ID: 21541750
[TBL] [Abstract][Full Text] [Related]
27. [Protective effect of a corpuscular polyvalent Pseudomonas aeruginosa vaccine in generalized chronic Pseudomonas aeruginosa infection in mice with cyclophosphamide-induced leukopenia].
Vetkova LG; Zaĭtsev LG; Khasman EL; Radkevich SA; Moroz AF
Zh Mikrobiol Epidemiol Immunobiol; 1986 Mar; (3):14-8. PubMed ID: 3085409
[TBL] [Abstract][Full Text] [Related]
28. The potential of Lactobacillus as a carrier for oral immunization: development and preliminary characterization of vector systems for targeted delivery of antigens.
Pouwels PH; Leer RJ; Boersma WJ
J Biotechnol; 1996 Jan; 44(1-3):183-92. PubMed ID: 8717402
[TBL] [Abstract][Full Text] [Related]
29. Human papillomavirus type 16 E6-specific antitumor immunity is induced by oral administration of HPV16 E6-expressing Lactobacillus casei in C57BL/6 mice.
Lee TY; Kim YH; Lee KS; Kim JK; Lee IH; Yang JM; Sung MH; Park JS; Poo H
Cancer Immunol Immunother; 2010 Nov; 59(11):1727-37. PubMed ID: 20706715
[TBL] [Abstract][Full Text] [Related]
30. Oral immunization with recombinant Lactobacillus casei expressing flaB confers protection against Aeromonas veronii challenge in common carp, Cyprinus carpio.
Kong YD; Kang YH; Tian JX; Zhang DX; Zhang L; Tao LT; Wu TL; Li Y; Wang GQ; Shan XF
Fish Shellfish Immunol; 2019 Apr; 87():627-637. PubMed ID: 30708057
[TBL] [Abstract][Full Text] [Related]
31. Effects of oral administration of Lactobacillus casei on antitumor responses induced by tumor resection in mice.
Kato I; Endo K; Yokokura T
Int J Immunopharmacol; 1994 Jan; 16(1):29-36. PubMed ID: 8150553
[TBL] [Abstract][Full Text] [Related]
32. A phase trial of the oral Lactobacillus casei vaccine polarizes Th2 cell immunity against transmissible gastroenteritis coronavirus infection.
Jiang X; Hou X; Tang L; Jiang Y; Ma G; Li Y
Appl Microbiol Biotechnol; 2016 Sep; 100(17):7457-69. PubMed ID: 27020282
[TBL] [Abstract][Full Text] [Related]
33. Postbiotics of Lactobacillus casei target virulence and biofilm formation of Pseudomonas aeruginosa by modulating quorum sensing.
Azami S; Arefian E; Kashef N
Arch Microbiol; 2022 Feb; 204(2):157. PubMed ID: 35106661
[TBL] [Abstract][Full Text] [Related]
34. Prevention of indigenous infection of mice with Escherichia coli by nonspecific immunostimulation.
Nomoto K; Yokokura T; Mitsuyama M; Yoshikai Y; Nomoto K
Antimicrob Agents Chemother; 1992 Feb; 36(2):361-7. PubMed ID: 1605602
[TBL] [Abstract][Full Text] [Related]
35. Coronary arteritis in mice following the systemic injection of group B Lactobacillus casei cell walls in aqueous suspension.
Lehman TJ; Walker SM; Mahnovski V; McCurdy D
Arthritis Rheum; 1985 Jun; 28(6):652-9. PubMed ID: 3924060
[TBL] [Abstract][Full Text] [Related]
36. Oral Immunization with
Li F; Wang X; Ma R; Wu W; Teng F; Cheng X; Jiang Y; Zhou H; Wang L; Tang L; Qiao X; Li Y
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372508
[TBL] [Abstract][Full Text] [Related]
37. Prevention of 5-fluorouracil-induced infection with indigenous Escherichia coli in tumor-bearing mice by nonspecific immunostimulation.
Nomoto K; Yokokura T; Nomoto K
Can J Microbiol; 1992 Aug; 38(8):774-8. PubMed ID: 1458370
[TBL] [Abstract][Full Text] [Related]
38. Protective immunity induced in mice by immunization with high-molecular-weight polysaccharide from Pseudomonas aeruginosa.
Pier GB; Sidberry HF; Sadoff JC
Infect Immun; 1978 Dec; 22(3):919-25. PubMed ID: 103841
[TBL] [Abstract][Full Text] [Related]
39. Systemic augmentation of the immune response in mice by feeding fermented milks with Lactobacillus casei and Lactobacillus acidophilus.
Perdigón G; de Macias ME; Alvarez S; Oliver G; de Ruiz Holgado AP
Immunology; 1988 Jan; 63(1):17-23. PubMed ID: 3123370
[TBL] [Abstract][Full Text] [Related]
40. The treatment of mice with Lactobacillus casei induces protection against Babesia microti infection.
Bautista-Garfias CR; Gómez MB; Aguilar BR; Ixta O; Martínez F; Mosqueda J
Parasitol Res; 2005 Dec; 97(6):472-7. PubMed ID: 16170567
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
